newsfilter
← Latest News
GlobeNewswire·

Trillium Therapeutics Appoints Michael Kamarck, Ph.D., to Its Board of Directors

CAMBRIDGE, Mass., Sept. 18, 2020 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative...